During the past decade, Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica" are "Breast Cancer" (1 trials), "Malignant Melanoma" (1 trials), "Metastatic Breast Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Urinary Tract Cancer" (1 trials). Many other conditions were trialed in "Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica" in a lesser frequency.

Most popular intervention types in "Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Docetaxel" (1 trials), "Pertuzumab" (1 trials), "Placebo" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".